The round was supported by the Viridian Growth Fund together with existing investors ACT and the University Challenge Fund. The investment will enable the company to accelerate its highly innovative R&D output and capitalise on growing market opportunities particularly in the US where “Good Samaritan” laws have mandated the provision of Automatic External Defibrillators (AEDs) in locations such as schools; dentist offices; airplanes and federal buildings.

With similar regulations expected to spread internationally, HeartSine anticipate significant demand for their simple yet effective emergency aid equipment over the next few years.